AGENUS INC — Director's Dealing 2021

Oct 20, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-13

Reporting Person: AGENUS INC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19481000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Convertible Promissory Note	$		Common Stock (5451958)		Direct

Footnotes

F1: The convertible promissory note has a maturity date of July 1, 2022, and will be automatically converted into common stock upon completion of the IPO at a rate equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the IPO.